A 2021 randomized controlled trial demonstrated that exenatide, a GLP-1 receptor agonist, significantly slowed cognitive decline in patients with early-stage Parkinsons disease compared to a placebo group (Athauda et al., 2021)
This is the proven science behind GLP-1 medications, also known as GLP-1 receptor agonists medicines built around glucagon-like peptide-1, a natural gut hormone, now more accessible in India in 2026
Know the cancellation process before you start so you're not surprised by billing if circumstances change
If you have struggled to reach your weight-loss goals through traditional methods, semaglutide may be an effective therapeutic option
National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007
Consider researching: What the common side effects are and how long they typically last What the long-term considerations like cost, sustainability, and lifestyle adjustments are The documentation below helps justify the need for GLP-1 therapy and can strengthen your case for insurance coverage if applicable